Cargando…
Inhibition of bromodomain-containing protein 4 enhances the migration of esophageal squamous cell carcinoma cells by inducing cell autophagy
BACKGROUND: Esophageal squamous cell carcinoma (ESCC), the predominant type of esophageal cancer, has a 5-year survival rate less than 20%. Although the cause of poor prognosis is the high incidence and mortality of ESCC, the high rate of metastasis after esophageal cancer surgery is the main cause...
Autores principales: | Yang, Wen-Qian, Liang, Rui, Gao, Man-Qi, Liu, Yu-Zhen, Qi, Bo, Zhao, Bao-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782615/ https://www.ncbi.nlm.nih.gov/pubmed/36568944 http://dx.doi.org/10.4251/wjgo.v14.i12.2340 |
Ejemplares similares
-
miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma
por: Feng, Jie, et al.
Publicado: (2017) -
N-linked glycoproteomic profiling in esophageal squamous cell carcinoma
por: Liu, Qi-Wei, et al.
Publicado: (2022) -
Berberine displays antitumor activity in esophageal cancer cells in vitro
por: Jiang, Shu-Xian, et al.
Publicado: (2017) -
KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling
por: Hao, Wei-Wei, et al.
Publicado: (2022) -
Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)